{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T22:48:38Z","timestamp":1783810118324,"version":"3.55.0"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"vor","delay-in-days":113,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The COVID-19 pandemic brought not only a huge healthcare challenge to the world but also introduced many questions of how the human immune system reacts to counter viral invasion, including vaccination. Unlike most vaccinations that are not usually linked to any specific skin eruptions, COVID-19 vaccination has been linked to a variety of skin lesions. In this paper, we present two patients who developed granulomatous skin lesions post-COVID-19 vaccination, one patient has generalised granuloma annulare (GA) and the other patient develops localised GA. Both patients have good responses to treatment regimens containing systemic corticosteroids. We review the literature pertaining to COVID-19-linked skin diseases, particularly granulomatous diseases and discuss the possible pathomechanism of granulomatous eruptions in relation to COVID-19 vaccination.<\/jats:p>","DOI":"10.1002\/ski2.412","type":"journal-article","created":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T02:46:11Z","timestamp":1721875571000},"source":"Crossref","is-referenced-by-count":2,"title":["COVID-19 Vaccination-Linked Granuloma Annulare in Two Patients"],"prefix":"10.1093","volume":"4","author":[{"given":"Emma","family":"McIntyre","sequence":"first","affiliation":[{"name":"Department of Dermatology, UC-Davis School of Medicine , Sacramento, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philina","family":"Lamb","sequence":"additional","affiliation":[{"name":"Department of Dermatology, UC-Davis School of Medicine , Sacramento, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxwell A.","family":"Fung","sequence":"additional","affiliation":[{"name":"Department of Dermatology, UC-Davis School of Medicine , Sacramento, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maija","family":"Kiuru","sequence":"additional","affiliation":[{"name":"Department of Dermatology, UC-Davis School of Medicine , Sacramento, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0640-980X","authenticated-orcid":false,"given":"Lawrence S.","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Dermatology, UC-Davis School of Medicine , Sacramento, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,7,24]]},"reference":[{"issue":"5","key":"2025112605520466900_ski2412-bib-0001","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.jaad.2021.01.023","article-title":"The clinical spectrum of COVID-19\u2013associated cutaneous manifestations: an Italian multicenter study of 200 adult patients","volume":"84","author":"Marzano","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"2025112605520466900_ski2412-bib-0002","doi-asserted-by":"publisher","first-page":"568","DOI":"10.4236\/aid.2022.123042","article-title":"COVID-19 infection: the virus and its origin, the variants, the immune defense, the multiorgan autoimmune reactions, and the targeted treatments","volume":"12","author":"Nguyen","year":"2022","journal-title":"Adv Infect Dis"},{"key":"2025112605520466900_ski2412-bib-0003","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jdin.2020.12.003","article-title":"Skin manifestations of COVID-19: a worldwide review","volume":"2","author":"Tan","year":"2021","journal-title":"JAAD international"},{"issue":"4","key":"2025112605520466900_ski2412-bib-0004","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1046\/j.1523-1747.2002.00200.x","article-title":"Pityriasis rosea is associated with systemic active infection with both human herpesvirus-7 and human herpesvirus-6","volume":"119","author":"Watanabe","year":"2002","journal-title":"J Invest Dermatol"},{"issue":"2","key":"2025112605520466900_ski2412-bib-0005","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/jdv.17744","article-title":"Cutaneous findings following COVID-19 vaccination: review of world literature and own experience","volume":"36","author":"Gambichler","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"2025112605520466900_ski2412-bib-0006","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jaad.2021.03.092","article-title":"Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases","volume":"85","author":"McMahon","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"2025112605520466900_ski2412-bib-0007","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jdcr.2022.05.003","article-title":"Generalized granuloma annulare after COVID-19 vaccination","volume":"25","author":"Nguyen","year":"2022","journal-title":"JAAD Case Reports"},{"issue":"7","key":"2025112605520466900_ski2412-bib-0008","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/pai.12762","article-title":"Vaccination and allergy: EAACI position paper, practical aspects","volume":"28","author":"Nilsson","year":"2017","journal-title":"Pediatr Allergy Immunol"},{"issue":"5","key":"2025112605520466900_ski2412-bib-0009","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1111\/j.1365-2125.2010.03774.x","article-title":"Epidemiology and risk factors for drug allergy","volume":"71","author":"Thong","year":"2011","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"2025112605520466900_ski2412-bib-0010","doi-asserted-by":"publisher","first-page":"20","DOI":"10.2500\/aap.2022.43.210105","article-title":"Delayed allergic skin reactions to vaccines","volume":"43","author":"Aquino","year":"2022","journal-title":"Allergy Asthma Proc"},{"issue":"2","key":"2025112605520466900_ski2412-bib-0011","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.13168","article-title":"Hydroxychloroquine in dermatology: new perspectives on an old drug","volume":"61","author":"Chew","year":"2019","journal-title":"Australas J Dermatol"},{"issue":"1","key":"2025112605520466900_ski2412-bib-0012","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s40257-021-00636-1","article-title":"Granuloma annulare: an updated review of epidemiology, pathogenesis, and treatment options","volume":"23","author":"Joshi","year":"2021","journal-title":"Am J Clin Dermatol"},{"key":"2025112605520466900_ski2412-bib-0013","volume-title":"UpToDate","author":"Brodell","year":"2021"},{"issue":"1","key":"2025112605520466900_ski2412-bib-0014","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.abd.2020.05.009","article-title":"Generalized granuloma annulare after pneumococcal vaccination","volume":"96","author":"Garc\u00eda-Gil","year":"2021","journal-title":"An Bras Dermatol"},{"issue":"3","key":"2025112605520466900_ski2412-bib-0015","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14897","article-title":"Granuloma annulare triggered by SARS-CoV-2 infection: immunohistochemical staining","volume":"34","author":"Monte-Serrano","year":"2021","journal-title":"Dermatol Ther"},{"issue":"2","key":"2025112605520466900_ski2412-bib-0016","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.jaci.2017.12.971","article-title":"Vaccine-associated hypersensitivity","volume":"141","author":"McNeil","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"2025112605520466900_ski2412-bib-0017","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.jaad.2015.03.055","article-title":"Granuloma annulare: pathogenesis, disease associations and triggers, and therapeutic options","volume":"75","author":"Piette","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"2025112605520466900_ski2412-bib-0018","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.clindermatol.2014.04.012","article-title":"Granulomatous dysimmune reactions (sarcoidosis, granuloma annulare, and others) on differently injured skin areas","volume":"32","author":"Ada","year":"2014","journal-title":"Clin Dermatol"}],"container-title":["Skin Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/4\/5\/ski2.412\/60660516\/skinhd_4_5_e412.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/4\/5\/ski2.412\/60660516\/skinhd_4_5_e412.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T10:52:07Z","timestamp":1764154327000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/skinhd\/article\/doi\/10.1002\/ski2.412\/7896801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,24]]},"references-count":18,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,7,24]]},"published-print":{"date-parts":[[2024,10,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ski2.412","relation":{},"ISSN":["2690-442X"],"issn-type":[{"value":"2690-442X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,10]]},"published":{"date-parts":[[2024,7,24]]},"article-number":"ski2.412"}}